Your search:
104 result(s) in 0.03 s
-
DUKAS_183263421_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Parkinson’s patient Keith Krehbiel wears a Medtronic device during his treatment with neurologist Dr. Helen Bronte-Stewart at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263416_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS) wears a Medtronic device during treatment with neurologist Gaurav Chattree, Stanford University, not pictured, at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263414_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Dr. Helen Bronte-Stewart works with Parkinson’s patient Keith Krehbiel during a treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263412_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS), walks in a hallway during his treatment with neurologist Gaurav Chattree, Stanford University (not pictured), and other medical professionals at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263410_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Dr. Helen Bronte-Stewart works with Parkinson’s patient Keith Krehbiel during a treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263406_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Dr. Helen Bronte-Stewart, left, and Pearl Yamaguchi, senior field clinical research manager for Medtronic, read a monitor while treating Parkinson’s patient Keith Krehbiel (not pictured) at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263403_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Dr. Helen Bronte-Stewart (not pictured) works with Parkinson’s patient Keith Krehbiel during a treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263402_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Dr. Helen Bronte-Stewart reads a monitor while treating Parkinson’s patient Keith Krehbiel (not pictured) at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263401_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Dr. Helen Bronte-Stewart works with Parkinson’s patient Keith Krehbiel during a treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263396_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Dr. Helen Bronte-Stewart (not pictured) works with Parkinson’s patient Keith Krehbiel during a treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263388_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Gaurav Chattree, second from right, Stanford University, converses with Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS), second from left, during treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263386_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Gaurav Chattree, Stanford University, monitors treatment with Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS), not pictured, at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263384_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Gaurav Chattree, Stanford University, monitors treatment with Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS), not pictured, at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263382_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS), walks in a hallway during his treatment with neurologist Gaurav Chattree, Stanford University (not pictured), and other medical professionals at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263380_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: (Left to right): Ken Washington, chief technology officer for Medtronic, and Rob Raike, director of research and technology for Medtronic Neuromodulation, watch live results of Parkinson’s patient John L. Lipp’s treatment with neurologist Gaurav Chattree, Stanford University (both not pictured), at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263378_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS), left, displays his motor skills to neurologist Gaurav Chattree, Stanford University (center), and engineer Shrav Ravi, emerging technology field technical consultant with Medtronic, during treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263376_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS), attends his treatment with neurologist Gaurav Chattree, Stanford University (not pictured), (not pictured) at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263373_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: (Left to right): Donna Gow, senior deep-brain stimulation (DBS) therapy specialist, San Francisco Bay Area, Medtronic, works with Parkinson’s patient Keith Krehbiel, during a treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263370_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: (Left to right): Neurologist Dr. Helen Bronte-Stewart works with Parkinson’s patient Keith Krehbiel as Pearl Yamaguchi, senior field clinical research manager for Medtronic, observes during a treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263369_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Dr. Helen Bronte-Stewart works with Parkinson’s patient Keith Krehbiel during a treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263366_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS), second from left, listens to neurologist Gaurav Chattree, not pictured, Stanford University, during treatment at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263364_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Parkinson’s patient John L. Lipp, CEO, Friends of the Alameda Animal Shelter (FAAS), attends his treatment with neurologist Gaurav Chattree, Stanford University (not pictured), (not pictured) at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263361_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: (Left to right): Amaza Reitmeier, VP and general manager of Neuromodulation Portfolio, Ken Washington, chief technology officer for Medtronic, Rob Raike, director of research and technology for Medtronic Neuromodulation, Angie Mason, district manager, Medtronic, and Meredith Vornholt, senior director of marketing at Brain Modulation, watch live results of Parkinson’s patient John L. Lipp’s treatment with neurologist Gaurav Chattree, Stanford University (both not pictured), at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263358_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: Neurologist Dr. Helen Bronte-Stewart speaks with medical professionals during a treatment with Parkinson’s patient Keith Krehbiel at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263355_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/21/2025 - Palo Alto, California, USA: (Left to right): Pearl Yamaguchi, senior field clinical research manager for Medtronic, Parkinson’s patient Keith Krehbiel, neurologist Dr. Helen Bronte-Stewart, and Donna Gow, senior deep-brain stimulation (DBS) therapy specialist, San Francisco Bay Area, Medtronic, work during a treatment with Krehbiel at the Stanford Neuroscience Health Center in Palo Alto, Calif. on Friday, March 21, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. For the first time in the U.S., Stanford experts are using it for patients. Krehbiel, 70, a recently retired political science and ethics professor at Stanford University, was diagnosed with Parkinson’s in 1997. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_159719822_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719776_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719785_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719790_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719788_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719774_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719772_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719807_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719782_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719817_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719783_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719786_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719773_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719811_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719810_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719803_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719809_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719781_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719823_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719784_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719808_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719806_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719802_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719778_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_159719818_EYE
'Martin Luther King told me I wouldn't see 50': the long, momentous life of Clarence B Jones
Dr Clarence B Jones was 29 when he went to work for the civil rights leader. As King's friend, adviser and speechwriter, he was at the heart of the attempt to reform the US. Six decades on, he remembers their battles and their triumphs.
Dr Clarence B Jones, photographed in Boston where he received his law degree at Boston University School of Law.
© Nine Acre Photography / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
